About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 139674, 9 pages
http://dx.doi.org/10.1155/2013/139674
Research Article

Gamma Knife Surgery as Monotherapy with Clinically Relevant Doses Prolongs Survival in a Human GBM Xenograft Model

1Department of Neurosurgery, Haukeland University Hospital, 5021 Bergen, Norway
2Institute of Surgical Sciences, Haukeland University Hospital, 5021 Bergen, Norway
3Oncomatrix Research Lab, Department of Biomedicine, University of Bergen, 5021 Bergen, Norway
4Department of Neurosurgery, Karolinska University Hospital, 171 76 Stockholm, Sweden
5Department of Oncology and Medical Physics, Haukeland University Hospital, 5021 Bergen, Norway
6Department of Biological and Medical Psychology, University of Bergen, 5021 Bergen, Norway
7Norwegian Competence Center for Sleep Disorders, Haukeland University Hospital, 5021 Bergen, Norway
8Brain Tumor Immunology & Therapy Group, Department of Biomedicine, University of Bergen, 5021 Bergen, Norway

Received 20 April 2013; Revised 17 September 2013; Accepted 19 September 2013

Academic Editor: Li Jiao

Copyright © 2013 Bente Sandvei Skeie et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Bente Sandvei Skeie, Jian Wang, Ernest Dodoo, et al., “Gamma Knife Surgery as Monotherapy with Clinically Relevant Doses Prolongs Survival in a Human GBM Xenograft Model,” BioMed Research International, vol. 2013, Article ID 139674, 9 pages, 2013. doi:10.1155/2013/139674